Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/31156
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24250458      Online Users : 503
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    CNU IR > Pharmacy and Science > 2015 >  Item 310902800/31156
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/31156


    Title: Lercanidipine and labedipinedilol-A play anti-inflammatory role through inhibition of lipopolysaccharide/interferon-γ-induced HMGB1 release and MMP-2, 9 activities in vascular smooth muscle cells
    Authors: Shu-Fen Liou(劉淑芬)
    Ling-Cheng Kao(高翎程)
    Contributors: Department and Graduate Institute of Pharmacology, College of Medicine, Kaohsiung Medical University
    Date: 2015-05-05
    Issue Date: 2018-03-27 10:24:14 (UTC+8)
    Abstract: Inflammation is an important molecular basis of atherosclerosis. Recent studies have shown that dihydropyridine calcium channel blockers (CCBs) can exert potent anti-inflammatory effects in models of vascular dysfunction. The purpose of the present study was to evaluate anti-inflammatory effects and mechanisms of lercanidipine and labedipinedilol-A, new generation dihydropyridine CCBs, in rat vascular smooth muscle cells (VSMCs) exposed to lipopolysaccharide (LPS) and interferon-γ (IFN-γ). MTT, Griess reagent, RT-PCR, ELISA, gelatin zymography, immunocytochemistry and Western blotting were employed. We found that lercanidipine and labedipinedilol-A attenuated production of NO, ROS, TNF-α and IL- from LPS/IFN-γ-stimulated VSMCs. In addition, they both diminished the LPS/IFN-γ-induced expression of iNOS protein and mRNA, with attenuation of HMGB1 cytosolic translocation and subsequent extracellular release.
    Furthermore, they down-regulated MMP-2/MMP-9 activities, while expression of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1), an inhibitor of MMP-9, was up-regulated. Finally, we found that lercanidipine and labedipinedilol-A inhibited the nuclear translocation of NF-κB and suppressed the phosphorylation of JNK, p38 MAPK and Akt. In conclusion, lercanidipine and labedipinedilol-A can exert their anti-inflammatory effects through suppression of NO, ROS, TNF-α and IL- through down-regulation of iNOS, MMP-2/MMP-9, and HMGB1, with inhibition of signaling transduction of MAPKs, Akt/IkB-α and NF-κB pathways. These findings implicate a valuable role of new generation dihydropyridine CCBs lercanidipine and labedipinedilol-A inthe treatment of inflammatory vascular diseases.
    Relation: 2015 第九屆嘉南藥理大學藥理學院師生研究成果發表會,起迄日:2015/05/05-2015/05/08,地點:嘉南藥理大學國際會議中心一樓
    Appears in Collections:[Pharmacy and Science] 2015

    Files in This Item:

    File Description SizeFormat
    B03.pdf595KbAdobe PDF241View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback